Nikhil Ghate

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (35)

• B1486 is a highly potent VprBP inhibitor capable of blocking osteoclast differentiation and bone resorption
  Journal of Biological Chemistry 2026 DOI: 10.1016/j.jbc.2026.113524
  +Save
• The multifaceted role of PUMA in cell death pathways: its therapeutic potential across cancer types
  Cell Communication and Signaling 2025 DOI: 10.1186/s12964-025-02112-3
  +Save
• Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer
  Nature Communications 2023 DOI: 10.1038/s41467-023-37883-1
  +Save
• VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation
  Oncogene 2023 DOI: 10.1038/s41388-023-02685-8
  +Save
• Editorial: Advancement in Cancer Stem Cell Biology and Precision Medicine
  Frontiers in Cell and Developmental Biology 2022 DOI: 10.3389/fcell.2022.890129
  +Save
• MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis
  Oncogene 2022 DOI: 10.1038/s41388-021-02109-5
  +Save
• Ameliorating effects of white mulberry on iron-overload-induced oxidative stress and liver fibrosis in Swiss albino mice
  Food and Chemical Toxicology 2021 DOI: 10.1016/j.fct.2021.112520
  +Save
• VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
  Molecular Oncology 2021 DOI: 10.1002/1878-0261.13068
  +Save
• DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis
  Epigenetics and Chromatin 2019 DOI: 10.1186/s13072-019-0270-0
  +Save
• p32 is a negative regulator of p53 tetramerization and transactivation
  Molecular Oncology 2019 DOI: 10.1002/1878-0261.12543
  +Save